BioSerenity builds wearable medical devices and digital point-of-care solutions that leverage sensor-equipped textiles, artificial intelligence, electronic patient-reported outcomes (ePRO), IoT and cloud technologies. The company offers fully-operated care services to hospitals and healthcare professionals and provides pharmaceutical companies with turnkey companion-diagnostic solutions. Its full-stack approach is intended to lower clinical costs, accelerate accurate diagnosis, and support treatment development through clinical and real-world data collection. BioSerenity’s initial clinical focus includes cardiovascular, neurology and sleep disorders. The company says it will expand its solutions beyond those areas and develop new telemedicine offerings. Founded in 2014 and headquartered in Paris, BioSerenity has been part of Dassault Systèmes’ 3DEXPERIENCE Lab.

Total raised

$73M

Funding rounds

1

Latest round

Series B

Latest activity

Jun 2019